Document And Entity Information
Document And Entity Information | Nov. 14, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Current Fiscal Year End Date | --12-31 |
Document Period End Date | Nov. 14, 2022 |
Entity Registrant Name | DICE THERAPEUTICS, INC. |
Entity Central Index Key | 0001645569 |
Entity Emerging Growth Company | true |
Securities Act File Number | 001-40794 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 47-2286244 |
Entity Address, Address Line One | 400 East Jamie Court, Suite 300 |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | 650 |
Local Phone Number | 566-1420 |
Entity Information, Former Legal or Registered Name | N/A |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Ex Transition Period | false |
Title of 12(b) Security | Common Stock, $0.0001 Par Value Per Share |
Trading Symbol | DICE |
Security Exchange Name | NASDAQ |